Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Cullinan Mica is raising $26,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Owen Hughes played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cullinan Mica

We combine a unique portfolio model with innovative sourcing techniques and drug development expertise to discover and advance candidates for potentially transformative oncology drugs. Cullinan leverages a wide range of relationships across the development spectrum to create, identify and develop promising science. Our internally-driven idea creation complements our externally focused business development activities as we look to create a portfolio of uncorrelated oncology assets. Recognizing no one entity has all the answers, Cullinan Prospecting seeks to leverage both internal and external resources to develop oncology medicines that can save lives.

To learn more about Cullinan Mica, visit http://www.cullinanoncology.com/

Contact:
Owen Hughes, Chief Executive Officer
858-750-4700
https://www.linkedin.com/in/owen-hughes-18a50477/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved